Bicycle Therapeutics Ownership 2024 | Who Owns Bicycle Therapeutics Now?
Institutional Ownership
12.99%
Insider Ownership
1.38%
Retail Ownership
85.62%
Institutional Holders
48.00
Bicycle Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 11.65% | 1.54% | 4,942,823 | 3,152,433 | 176.08% | 123,076,293 | Mar 31, 2024 |
| DEEP TRACK CAPITAL, LP | 8.23% | 2.49% | 3,490,506 | - | - | 86,913,599 | Mar 31, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 7.65% | 2.85% | 3,246,759 | -460,242 | -12.42% | 80,844,299 | Mar 31, 2024 |
| ARMISTICE CAPITAL, LLC | 3.94% | 0.55% | 1,672,000 | 136,000 | 8.85% | 41,632,800 | Mar 31, 2024 |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 3.64% | 6.58% | 1,545,026 | -105,294 | -6.38% | 38,471,148 | Mar 31, 2024 |
| MORGAN STANLEY | 3.58% | 0.00% | 1,516,715 | 487,490 | 47.36% | 37,766,203 | Mar 31, 2024 |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 2.81% | 2.27% | 1,193,051 | -357,420 | -23.05% | 29,706,970 | Mar 31, 2024 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2.45% | 0.14% | 1,038,917 | 121,613 | 13.26% | 25,869,033 | Mar 31, 2024 |
| POLAR CAPITAL HOLDINGS PLC | 2.37% | 0.13% | 1,004,535 | - | - | 25,012,922 | Mar 31, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2.16% | 0.85% | 914,476 | - | - | 22,770,452 | Mar 31, 2024 |
| CANDRIAM S.C.A. | 2.10% | 0.14% | 889,258 | 20,000 | 2.30% | 22,142,524 | Mar 31, 2024 |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 2.08% | 0.06% | 883,105 | 100,107 | 12.79% | 21,989,000 | Mar 31, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 1.89% | 0.03% | 800,000 | - | - | 19,920,000 | Mar 31, 2024 |
| BLACKROCK INC. | 1.36% | 0.00% | 575,030 | 73,407 | 14.63% | 14,318,247 | Mar 31, 2024 |
| AXA S.A. | 1.31% | 0.04% | 554,163 | 77 | 0.01% | 13,798,659 | Mar 31, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 1.24% | 1.60% | 524,253 | 211,364 | 67.55% | 13,053,900 | Mar 31, 2024 |
| CAMBER CAPITAL MANAGEMENT LP | 1.06% | 0.27% | 450,000 | - | - | 11,205,000 | Mar 31, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.99% | 0.07% | 420,800 | 313,800 | 293.27% | 10,477,920 | Mar 31, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.95% | 0.00% | 401,646 | 124,809 | 45.08% | 10,001,000 | Mar 31, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.94% | 0.00% | 396,812 | -64,519 | -13.99% | 9,880,620,000 | Mar 31, 2024 |
Bicycle Therapeutics's largest institutional shareholder is BAKER BROS. ADVISORS LP, holding 11.65% of the company's total share outstanding, currently valued at $123.08M. The top 10 institutional shareholders own together 48.48% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 3.64% | 6.58% | 1,545,026 | -105,294 | -6.38% | 38,471,148 | Mar 31, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 7.65% | 2.85% | 3,246,759 | -460,242 | -12.42% | 80,844,299 | Mar 31, 2024 |
| DEEP TRACK CAPITAL, LP | 8.23% | 2.49% | 3,490,506 | - | - | 86,913,599 | Mar 31, 2024 |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 2.81% | 2.27% | 1,193,051 | -357,420 | -23.05% | 29,706,970 | Mar 31, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 1.24% | 1.60% | 524,253 | 211,364 | 67.55% | 13,053,900 | Mar 31, 2024 |
| BAKER BROS. ADVISORS LP | 11.65% | 1.54% | 4,942,823 | 3,152,433 | 176.08% | 123,076,293 | Mar 31, 2024 |
| HIGHVISTA STRATEGIES LLC | 0.37% | 1.41% | 158,293 | - | - | 3,941,496 | Mar 31, 2024 |
| ALPHACENTRIC ADVISORS LLC | 0.14% | 0.90% | 60,000 | 60,000 | 100.00% | 1,494,000 | Mar 31, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2.16% | 0.85% | 914,476 | - | - | 22,770,452 | Mar 31, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 0.29% | 0.69% | 122,200 | - | - | 3,042,780 | Mar 31, 2024 |
| ARMISTICE CAPITAL, LLC | 3.94% | 0.55% | 1,672,000 | 136,000 | 8.85% | 41,632,800 | Mar 31, 2024 |
| PLATINUM INVESTMENT MANAGEMENT LTD | 0.79% | 0.33% | 333,001 | -29,079 | -8.03% | 8,291,725 | Mar 31, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 0.36% | 0.28% | 153,000 | 58,000 | 61.05% | 3,809,700 | Mar 31, 2024 |
| CAMBER CAPITAL MANAGEMENT LP | 1.06% | 0.27% | 450,000 | - | - | 11,205,000 | Mar 31, 2024 |
| WEXFORD CAPITAL LP | 0.08% | 0.18% | 34,879 | - | - | 868,487 | Mar 31, 2024 |
| UBS OCONNOR LLC | 0.20% | 0.15% | 84,980 | 11,379 | 15.46% | 2,116,002 | Mar 31, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | 0.48% | 0.15% | 205,423 | - | - | 5,115,033 | Mar 31, 2024 |
| CANDRIAM S.C.A. | 2.10% | 0.14% | 889,258 | 20,000 | 2.30% | 22,142,524 | Mar 31, 2024 |
| HARBOR CAPITAL ADVISORS, INC. | 0.10% | 0.14% | 43,480 | 16,792 | 62.92% | 1,083,000 | Mar 31, 2024 |
| L & S ADVISORS INC | 0.12% | 0.14% | 50,260 | 40,070 | 393.23% | 1,251,474 | Mar 31, 2024 |
The largest Bicycle Therapeutics shareholder by % of total assets is TYBOURNE CAPITAL MANAGEMENT (HK) LTD. The company owns 1.55M shares of Bicycle Therapeutics (BCYC), representing 6.58% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 11.65% | 1.54% | 4,942,823 | 3,152,433 | 176.08% | 123,076,293 | Mar 31, 2024 |
| MORGAN STANLEY | 3.58% | 0.00% | 1,516,715 | 487,490 | 47.36% | 37,766,203 | Mar 31, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.99% | 0.07% | 420,800 | 313,800 | 293.27% | 10,477,920 | Mar 31, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 1.24% | 1.60% | 524,253 | 211,364 | 67.55% | 13,053,900 | Mar 31, 2024 |
| DUQUESNE FAMILY OFFICE LLC | 0.45% | 0.11% | 190,200 | 190,200 | 100.00% | 4,736,000 | Mar 31, 2024 |
| ARMISTICE CAPITAL, LLC | 3.94% | 0.55% | 1,672,000 | 136,000 | 8.85% | 41,632,800 | Mar 31, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.95% | 0.00% | 401,646 | 124,809 | 45.08% | 10,001,000 | Mar 31, 2024 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2.45% | 0.14% | 1,038,917 | 121,613 | 13.26% | 25,869,033 | Mar 31, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.81% | 0.02% | 342,594 | 116,699 | 51.66% | 8,530,591 | Mar 31, 2024 |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 2.08% | 0.06% | 883,105 | 100,107 | 12.79% | 21,989,000 | Mar 31, 2024 |
| PINNACLE ASSOCIATES LTD | 0.19% | 0.03% | 80,090 | 80,090 | 100.00% | 1,994,241 | Mar 31, 2024 |
| BLACKROCK INC. | 1.36% | 0.00% | 575,030 | 73,407 | 14.63% | 14,318,247 | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.39% | 0.01% | 165,700 | 60,200 | 57.06% | 4,126,000 | Mar 31, 2024 |
| ALPHACENTRIC ADVISORS LLC | 0.14% | 0.90% | 60,000 | 60,000 | 100.00% | 1,494,000 | Mar 31, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 0.36% | 0.28% | 153,000 | 58,000 | 61.05% | 3,809,700 | Mar 31, 2024 |
| GOLDMAN SACHS GROUP INC | 0.13% | 0.00% | 55,450 | 55,450 | 100.00% | 1,380,705 | Mar 31, 2024 |
| NATIONAL BANK OF CANADA /FI/ | 0.11% | 0.00% | 48,700 | 48,700 | 100.00% | 1,114,743 | Mar 31, 2024 |
| SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | 0.10% | 0.01% | 42,729 | 42,729 | 100.00% | 1,063,525 | Mar 31, 2024 |
| L & S ADVISORS INC | 0.12% | 0.14% | 50,260 | 40,070 | 393.23% | 1,251,474 | Mar 31, 2024 |
| HANDELSBANKEN FONDER AB | 0.42% | 0.02% | 179,800 | 40,000 | 28.61% | 4,477,000 | Mar 31, 2024 |
As of Mar 31 2024, Bicycle Therapeutics's largest institutional buyer is BAKER BROS. ADVISORS LP. The company purchased 3.15M stocks of BCYC, valued at $123.08M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JEFFERIES FINANCIAL GROUP INC. | - | - | - | -1,948,000 | -100.00% | - | Mar 31, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 7.65% | 2.85% | 3,246,759 | -460,242 | -12.42% | 80,844,299 | Mar 31, 2024 |
| NOMURA HOLDINGS INC | - | - | - | -400,000 | -100.00% | - | Mar 31, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.80% | 0.06% | 340,866 | -399,673 | -53.97% | 8,487,563 | Mar 31, 2024 |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 2.81% | 2.27% | 1,193,051 | -357,420 | -23.05% | 29,706,970 | Mar 31, 2024 |
| FMR LLC | - | - | - | -266,347 | -100.00% | - | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -249,135 | -100.00% | - | Mar 31, 2024 |
| CITADEL ADVISORS LLC | 0.14% | 0.00% | 59,440 | -235,025 | -79.81% | 1,480,056 | Mar 31, 2024 |
| MAN GROUP PLC | - | - | - | -174,074 | -100.00% | - | Mar 31, 2024 |
| KENNEDY CAPITAL MANAGEMENT LLC | 0.59% | 0.13% | 252,172 | -164,313 | -39.45% | 6,279,083 | Mar 31, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -150,126 | -100.00% | - | Mar 31, 2024 |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 3.64% | 6.58% | 1,545,026 | -105,294 | -6.38% | 38,471,148 | Mar 31, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.02% | 0.00% | 9,420 | -104,481 | -91.73% | 234,558 | Mar 31, 2024 |
| TREXQUANT INVESTMENT LP | 0.22% | 0.05% | 92,552 | -103,771 | -52.86% | 2,304,545 | Mar 31, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -77,332 | -100.00% | - | Mar 31, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.07% | 0.00% | 28,585 | -75,043 | -72.42% | 711,766 | Mar 31, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.94% | 0.00% | 396,812 | -64,519 | -13.99% | 9,880,620,000 | Mar 31, 2024 |
| JANE STREET GROUP, LLC | 0.05% | 0.00% | 20,197 | -62,753 | -75.65% | 502,906 | Mar 31, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.03% | 0.08% | 14,430 | -60,395 | -80.72% | 359,307 | Mar 31, 2024 |
| UBS OCONNOR LLC | 0.17% | 0.01% | 70,000 | -55,000 | -44.00% | 129,500 | Mar 31, 2024 |
As of Mar 31 2024, Bicycle Therapeutics's biggest institutional seller is JEFFERIES FINANCIAL GROUP INC.. The company sold -1.95M shares of BCYC, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DUQUESNE FAMILY OFFICE LLC | 0.45% | 0.11% | 190,200 | 190,200 | 100.00% | 4,736,000 | Mar 31, 2024 |
| PINNACLE ASSOCIATES LTD | 0.19% | 0.03% | 80,090 | 80,090 | 100.00% | 1,994,241 | Mar 31, 2024 |
| GOLDMAN SACHS GROUP INC | 0.13% | 0.00% | 55,450 | 55,450 | 100.00% | 1,380,705 | Mar 31, 2024 |
| NATIONAL BANK OF CANADA /FI/ | 0.11% | 0.00% | 48,700 | 48,700 | 100.00% | 1,114,743 | Mar 31, 2024 |
| SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | 0.10% | 0.01% | 42,729 | 42,729 | 100.00% | 1,063,525 | Mar 31, 2024 |
| CONCURRENT INVESTMENT ADVISORS, LLC | 0.05% | 0.02% | 21,799 | 21,799 | 100.00% | 542,796 | Mar 31, 2024 |
| GILDER GAGNON HOWE & CO LLC | 0.05% | 0.01% | 21,268 | 21,268 | 100.00% | 529,573 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.02% | - | 9,100 | 9,100 | 100.00% | 226,590 | Mar 31, 2024 |
| PDS PLANNING, INC | 0.02% | 0.02% | 8,450 | 8,450 | 100.00% | 210,405 | Mar 31, 2024 |
| US BANCORP \DE\ | 0.00% | - | 300 | 300 | 100.00% | 7,470 | Mar 31, 2024 |
| 0.00% | 0.00% | 39 | 39 | 100.00% | 971 | Mar 31, 2024 |
Bicycle Therapeutics's largest new institutional shareholder by number of shares is DUQUESNE FAMILY OFFICE LLC, purchased 190.20K shares, valued at $4.74M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JEFFERIES FINANCIAL GROUP INC. | - | - | - | -1,948,000 | -100.00% | - | Mar 31, 2024 |
| NOMURA HOLDINGS INC | - | - | - | -400,000 | -100.00% | - | Mar 31, 2024 |
| FMR LLC | - | - | - | -266,347 | -100.00% | - | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -249,135 | -100.00% | - | Mar 31, 2024 |
| MAN GROUP PLC | - | - | - | -174,074 | -100.00% | - | Mar 31, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -150,126 | -100.00% | - | Mar 31, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -77,332 | -100.00% | - | Mar 31, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | - | - | - | -54,100 | -100.00% | - | Mar 31, 2024 |
| HRT FINANCIAL LP | - | - | - | -19,913 | -100.00% | - | Mar 31, 2024 |
| ENTRYPOINT CAPITAL, LLC | - | - | - | -18,495 | -100.00% | - | Mar 31, 2024 |
| PEAK6 INVESTMENTS LLC | - | - | - | -6,000 | -100.00% | - | Mar 31, 2024 |
| AQUATIC CAPITAL MANAGEMENT LLC | - | - | - | -4,500 | -100.00% | - | Mar 31, 2024 |
| ARETE WEALTH ADVISORS, LLC | - | - | - | -3,772 | -100.00% | - | Mar 31, 2024 |
| CLEAR STREET MARKETS LLC | - | - | - | -1,500 | -100.00% | - | Mar 31, 2024 |
| QUANTBOT TECHNOLOGIES LP | - | - | - | -400 | -100.00% | - | Mar 31, 2024 |
| RONALD BLUE TRUST, INC. | - | - | - | -138 | -100.00% | - | Mar 31, 2024 |
| ADVISORY SERVICES NETWORK, LLC | - | - | - | -115 | -100.00% | - | Mar 31, 2024 |
| ARLINGTON TRUST CO LLC | - | - | - | -53 | -100.00% | - | Mar 31, 2024 |
Bicycle Therapeutics's largest sold out institutional shareholder by shares sold is JEFFERIES FINANCIAL GROUP INC., sold -1.95M shares, valued at -, as of undefined.
Bicycle Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| BlackRock Health Sciences Trust II | 0.10% | 278,270 | 219,670 | 374.86% | Dec 31, 2023 |
| TEKLA LIFE SCIENCES INVESTORS | 0.08% | 44,338 | - | - | Dec 31, 2023 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.04% | 201,468 | -257,548 | -56.11% | Dec 31, 2023 |
| Listed Funds Trust | 0.03% | 14,396 | - | - | Feb 29, 2024 |
| VICTORY VARIABLE INSURANCE FUNDS | 0.02% | 10,860 | - | - | Dec 31, 2023 |
| HARBOR FUNDS | 0.02% | 425,769 | 405,948 | 2048.07% | Jan 31, 2024 |
| DEUTSCHE DWS SECURITIES TRUST | 0.02% | 8,070 | - | - | Feb 29, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.01% | 120,100 | - | - | Jan 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.01% | 150,971 | - | - | Dec 31, 2023 |
| T. Rowe Price Equity Series, Inc. | 0.01% | 9,604 | -11,900 | -55.34% | Dec 31, 2023 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 266,347 | - | - | Feb 29, 2024 |
| ETFis Series Trust I | 0.00% | 5,471 | 1,766 | 47.67% | Jan 31, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.00% | 28,782 | - | - | Dec 29, 2023 |
| Harbor ETF Trust | 0.00% | 11,268 | 3,000 | 36.28% | Jan 31, 2024 |
| FIDELITY SECURITIES FUND | 0.00% | 214,959 | - | - | Jan 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 5,125 | - | - | Mar 31, 2024 |
| AdvisorShares Trust | 0.00% | 5,344 | - | - | Dec 29, 2023 |
| ALPS ETF Trust | 0.00% | 18,751 | - | - | Feb 29, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 41,308 | - | - | Feb 29, 2024 |
| BlackRock ETF Trust | 0.00% | 570 | 394 | 223.86% | Jan 31, 2024 |
| ETF Series Solutions | 0.00% | 7,914 | 1,267 | 19.06% | Feb 29, 2024 |
| SPDR INDEX SHARES FUNDS | 0.00% | 35,866 | - | - | Dec 31, 2023 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 19,120 | 19,120 | - | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 5,197 | - | - | Dec 29, 2023 |
| RBB FUND, INC. | 0.00% | 14,975 | - | - | Feb 29, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 2,928 | - | - | Dec 31, 2023 |
| LOOMIS SAYLES FUNDS II | 0.00% | 368,341 | - | - | Dec 31, 2023 |
| Virtus Investment Trust | 0.00% | 3,185 | - | - | Dec 29, 2023 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 19,506 | 2,362 | 13.78% | Feb 29, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND II | 0.00% | 447 | - | - | Dec 31, 2023 |
| FIDELITY CAPITAL TRUST | 0.00% | 486 | - | - | Jan 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 83,657 | - | - | Dec 31, 2023 |
| MUTUAL FUND SERIES TRUST | 0.00% | 90,000 | 31,500 | 53.85% | Dec 31, 2023 |
| Blackstone Alternative Investment Funds | 0.00% | 2,600 | -300 | -10.34% | Dec 31, 2023 |
| iSHARES TRUST | 0.00% | 202,695 | - | - | Feb 29, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 3,228 | 1,240 | 62.37% | Feb 29, 2024 |
| PROSHARES TRUST | 0.00% | 2,583 | 899 | 53.38% | Feb 29, 2024 |
| Goldman Sachs Trust II | 0.00% | 55,810 | 44,300 | 384.88% | Jan 31, 2024 |
| Bridge Builder Trust | 0.00% | 56,026 | - | - | Dec 31, 2023 |
| EQ ADVISORS TRUST | 0.00% | 7,968 | 1,751 | 28.16% | Dec 31, 2023 |
| ADVANCED SERIES TRUST | 0.00% | 20,740 | - | - | Dec 29, 2023 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 10,444 | - | - | Dec 31, 2023 |
| TRUST FOR PROFESSIONAL MANAGERS | 0.00% | 1,041 | -3,356 | -76.32% | Feb 29, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 831 | - | - | Dec 31, 2023 |
| John Hancock Funds II | 0.00% | 4,984 | -6,055 | -54.85% | Feb 29, 2024 |
Bicycle Therapeutics's largest mutual fund holder by % of total assets is "BlackRock Health Sciences Trust II", owning 278.27K shares, compromising 0.10% of its total assets.
Bicycle Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 24 | 48 | -53.85% |
| 31 Dec, 23 | 104 | 2.97% |
| 30 Sep, 23 | 101 | 17.44% |
| 30 Jun, 23 | 86 | -7.53% |
| 31 Mar, 23 | 93 | 5.68% |
| 31 Dec, 22 | 88 | 15.79% |
| 30 Sep, 22 | 76 | -5.00% |
| 30 Jun, 22 | 80 | -27.93% |
| 31 Mar, 22 | 111 | 12.12% |
| 31 Dec, 21 | 99 | 39.44% |
| 30 Sep, 21 | 71 | 33.96% |
| 30 Jun, 21 | 53 | 35.90% |
| 31 Mar, 21 | 39 | 44.44% |
| 31 Dec, 20 | 27 | 50.00% |
| 30 Sep, 20 | 18 | 20.00% |
| 30 Jun, 20 | 15 | 15.38% |
| 31 Mar, 20 | 13 | 62.50% |
| 31 Dec, 19 | 8 | -27.27% |
| 30 Sep, 19 | 11 | -21.43% |
| 30 Jun, 19 | 14 | - |
As of 31 Mar 24, 48 institutions are holding Bicycle Therapeutics's shares, representing a decrease of -53.85% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 24 | 5,511,844 | -82.41% |
| 31 Dec, 23 | 31,340,809 | -3.07% |
| 30 Sep, 23 | 32,334,285 | 33.13% |
| 30 Jun, 23 | 24,288,520 | 3.35% |
| 31 Mar, 23 | 23,500,248 | -0.17% |
| 31 Dec, 22 | 23,540,458 | 1.84% |
| 30 Sep, 22 | 23,115,335 | 1.85% |
| 30 Jun, 22 | 22,695,867 | 12.45% |
| 31 Mar, 22 | 20,182,855 | -6.33% |
| 31 Dec, 21 | 21,547,783 | 51.83% |
| 30 Sep, 21 | 14,192,093 | 14.34% |
| 30 Jun, 21 | 12,412,639 | 8.68% |
| 31 Mar, 21 | 11,420,900 | 55.84% |
| 31 Dec, 20 | 7,328,447 | -2.94% |
| 30 Sep, 20 | 7,550,163 | 20.08% |
| 30 Jun, 20 | 6,287,837 | 5.19% |
| 31 Mar, 20 | 5,977,354 | 1.28% |
| 31 Dec, 19 | 5,901,993 | -8.44% |
| 30 Sep, 19 | 6,446,149 | -2.85% |
| 30 Jun, 19 | 6,635,216 | - |
Bicycle Therapeutics (BCYC) has 5.51M shares outstanding as of 31 Mar 24, down -82.41% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 24 | 12.99% | 0.21% |
| 31 Dec, 23 | 79.19% | 0.69% |
| 30 Sep, 23 | 107.10% | 1.63% |
| 30 Jun, 23 | 80.96% | 1.32% |
| 31 Mar, 23 | 78.33% | 1.24% |
| 31 Dec, 22 | 79.37% | 1.31% |
| 30 Sep, 22 | 77.89% | 1.33% |
| 30 Jun, 22 | 76.55% | 1.65% |
| 31 Mar, 22 | 68.17% | 1.22% |
| 31 Dec, 21 | 74.84% | 2.33% |
| 30 Sep, 21 | 56.68% | 2.13% |
| 30 Jun, 21 | 51.61% | 1.93% |
| 31 Mar, 21 | 51.68% | 4.27% |
| 31 Dec, 20 | 34.80% | 2.30% |
| 30 Sep, 20 | 38.86% | 3.21% |
| 30 Jun, 20 | 34.78% | 3.15% |
| 31 Mar, 20 | 33.21% | 1.16% |
| 31 Dec, 19 | 53.43% | 1.57% |
| 30 Sep, 19 | 58.36% | 0.71% |
| 30 Jun, 19 | 90.92% | - |
As of 31 Mar 24, Bicycle Therapeutics is held by 12.99% institutional shareholders, representing a 0.21% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 28 | -50.00% |
| 31 Dec, 23 | 56 | -3.45% |
| 30 Sep, 23 | 58 | 52.63% |
| 30 Jun, 23 | 38 | -24.00% |
| 31 Mar, 23 | 50 | 47.06% |
| 31 Dec, 22 | 34 | 13.33% |
| 30 Sep, 22 | 30 | -37.50% |
| 30 Jun, 22 | 48 | -5.88% |
| 31 Mar, 22 | 51 | -23.88% |
| 31 Dec, 21 | 67 | 91.43% |
| 30 Sep, 21 | 35 | 6.06% |
| 30 Jun, 21 | 33 | 26.92% |
| 31 Mar, 21 | 26 | 62.50% |
| 31 Dec, 20 | 16 | 128.57% |
| 30 Sep, 20 | 7 | - |
| 30 Jun, 20 | 7 | - |
| 31 Mar, 20 | 7 | 600.00% |
| 31 Dec, 19 | 1 | -66.67% |
| 30 Sep, 19 | 3 | -78.57% |
| 30 Jun, 19 | 14 | - |
28 institutional shareholders have increased their position in BCYC stock as of 31 Mar 24 compared to 56 in the previous quarter (a -50.00% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 12 | -61.29% |
| 31 Dec, 23 | 31 | 34.78% |
| 30 Sep, 23 | 23 | -17.86% |
| 30 Jun, 23 | 28 | 55.56% |
| 31 Mar, 23 | 18 | -47.06% |
| 31 Dec, 22 | 34 | 17.24% |
| 30 Sep, 22 | 29 | 81.25% |
| 30 Jun, 22 | 16 | -62.79% |
| 31 Mar, 22 | 43 | 72.00% |
| 31 Dec, 21 | 25 | 4.17% |
| 30 Sep, 21 | 24 | 84.62% |
| 30 Jun, 21 | 13 | 85.71% |
| 31 Mar, 21 | 7 | 40.00% |
| 31 Dec, 20 | 5 | -28.57% |
| 30 Sep, 20 | 7 | 250.00% |
| 30 Jun, 20 | 2 | -33.33% |
| 31 Mar, 20 | 3 | -25.00% |
| 31 Dec, 19 | 4 | - |
| 30 Sep, 19 | 4 | - |
| 30 Jun, 19 | - | - |
12 institutional shareholders have reduced their position in BCYC stock as of 31 Mar 24 compared to 31 in the previous quarter (a -61.29% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 24 | 48 | -53.85% | 5,511,844 | -82.41% | 12.99% | 0.21% | 28 | -50.00% | 12 | -61.29% |
| 31 Dec, 23 | 104 | 2.97% | 31,340,809 | -3.07% | 79.19% | 0.69% | 56 | -3.45% | 31 | 34.78% |
| 30 Sep, 23 | 101 | 17.44% | 32,334,285 | 33.13% | 107.10% | 1.63% | 58 | 52.63% | 23 | -17.86% |
| 30 Jun, 23 | 86 | -7.53% | 24,288,520 | 3.35% | 80.96% | 1.32% | 38 | -24.00% | 28 | 55.56% |
| 31 Mar, 23 | 93 | 5.68% | 23,500,248 | -0.17% | 78.33% | 1.24% | 50 | 47.06% | 18 | -47.06% |
| 31 Dec, 22 | 88 | 15.79% | 23,540,458 | 1.84% | 79.37% | 1.31% | 34 | 13.33% | 34 | 17.24% |
| 30 Sep, 22 | 76 | -5.00% | 23,115,335 | 1.85% | 77.89% | 1.33% | 30 | -37.50% | 29 | 81.25% |
| 30 Jun, 22 | 80 | -27.93% | 22,695,867 | 12.45% | 76.55% | 1.65% | 48 | -5.88% | 16 | -62.79% |
| 31 Mar, 22 | 111 | 12.12% | 20,182,855 | -6.33% | 68.17% | 1.22% | 51 | -23.88% | 43 | 72.00% |
| 31 Dec, 21 | 99 | 39.44% | 21,547,783 | 51.83% | 74.84% | 2.33% | 67 | 91.43% | 25 | 4.17% |
| 30 Sep, 21 | 71 | 33.96% | 14,192,093 | 14.34% | 56.68% | 2.13% | 35 | 6.06% | 24 | 84.62% |
| 30 Jun, 21 | 53 | 35.90% | 12,412,639 | 8.68% | 51.61% | 1.93% | 33 | 26.92% | 13 | 85.71% |
| 31 Mar, 21 | 39 | 44.44% | 11,420,900 | 55.84% | 51.68% | 4.27% | 26 | 62.50% | 7 | 40.00% |
| 31 Dec, 20 | 27 | 50.00% | 7,328,447 | -2.94% | 34.80% | 2.30% | 16 | 128.57% | 5 | -28.57% |
| 30 Sep, 20 | 18 | 20.00% | 7,550,163 | 20.08% | 38.86% | 3.21% | 7 | - | 7 | 250.00% |
| 30 Jun, 20 | 15 | 15.38% | 6,287,837 | 5.19% | 34.78% | 3.15% | 7 | - | 2 | -33.33% |
| 31 Mar, 20 | 13 | 62.50% | 5,977,354 | 1.28% | 33.21% | 1.16% | 7 | 600.00% | 3 | -25.00% |
| 31 Dec, 19 | 8 | -27.27% | 5,901,993 | -8.44% | 53.43% | 1.57% | 1 | -66.67% | 4 | - |
| 30 Sep, 19 | 11 | -21.43% | 6,446,149 | -2.85% | 58.36% | 0.71% | 3 | -78.57% | 4 | - |
| 30 Jun, 19 | 14 | - | 6,635,216 | - | 90.92% | - | 14 | - | - | - |
Bicycle Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Bicycle Therapeutics's stock was made by Hannay Michael Charles Ferguson on Apr 12 2024, selling 257 shares at $22.49 per share (valued at $5.78K).
Bicycle Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | 7 | - |
| Q1 2024 | 33 | 10 | 330.00% |
| Q4 2023 | - | 6 | - |
| Q3 2023 | 1 | 6 | 16.67% |
| Q2 2023 | - | 13 | - |
| Q1 2023 | 27 | 7 | 385.71% |
| Q1 2022 | 27 | 2 | 1350.00% |
| Q4 2021 | 4 | 14 | 28.57% |
| Q3 2021 | 23 | 65 | 35.38% |
| Q2 2021 | 11 | 31 | 35.48% |
| Q1 2021 | 18 | 23 | 78.26% |
| Q4 2020 | 4 | 9 | 44.44% |
| Q3 2020 | 1 | 3 | 33.33% |
| Q2 2020 | 1 | 1 | 100.00% |
| Q1 2020 | 14 | - | - |
| Q4 2019 | 1 | - | - |
| Q3 2019 | 4 | - | - |
| Q2 2019 | 58 | 51 | 113.73% |
0 total buy trades, and 7 total sell trades (buy/sell ratio of 0.00%) were made by Bicycle Therapeutics's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | 7 | - |
| Q1 2024 | - | 6 | - |
| Q4 2023 | - | 6 | - |
| Q3 2023 | - | 6 | - |
| Q2 2023 | - | 6 | - |
| Q1 2023 | - | 7 | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | 10 | - |
| Q3 2021 | - | 42 | - |
| Q2 2021 | - | 20 | - |
| Q1 2021 | - | 18 | - |
| Q4 2020 | - | 5 | - |
| Q3 2020 | - | 3 | - |
| Q2 2020 | - | - | - |
| Q1 2020 | - | - | - |
| Q4 2019 | - | - | - |
| Q3 2019 | - | - | - |
| Q2 2019 | 11 | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 7 open market sell trades of Bicycle Therapeutics's stocks.
Bicycle Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| ANEB | Anebulo Pharmaceuticals, Inc. |
| MLYS | Mineralys Therapeutics, Inc. |
| ANAB | AnaptysBio, Inc. |
| CCCC | C4 Therapeutics, Inc. |
| MRUS | Merus N.V. |
| KROS | Keros Therapeutics, Inc. |
| ORIC | ORIC Pharmaceuticals, Inc. |
| IDYA | IDEAYA Biosciences, Inc. |
| INBX | Inhibrx, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| SEER | Seer, Inc. |
| ACRV | Acrivon Therapeutics, Inc. Common Stock |
| TNYA | Tenaya Therapeutics, Inc. |
| CGEM | Cullinan Oncology, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| MGTX | MeiraGTx Holdings plc |
| IGMS | IGM Biosciences, Inc. |
| ADAG | Adagene Inc. |
| FIXX | Q32 Bio Inc. |
BCYC Ownership FAQ
Who Owns Bicycle Therapeutics?
Bicycle Therapeutics is owned by institutional shareholders (12.99%), insiders (1.38%), and public (85.62%). The largest institutional shareholder of Bicycle Therapeutics is BAKER BROS. ADVISORS LP (11.65% of total shares) and the top mutual fund owner is BlackRock Health Sciences Trust II (0.10% of total shares).
Who are the major institutional shareholders of Bicycle Therapeutics?
Bicycle Therapeutics's major institutional shareholders are BAKER BROS. ADVISORS LP, DEEP TRACK CAPITAL, LP, PARADIGM BIOCAPITAL ADVISORS LP, ARMISTICE CAPITAL, LLC, and TYBOURNE CAPITAL MANAGEMENT (HK) LTD. The top five shareholders own together 35.12% of the company's share outstanding.
How many Bicycle Therapeutics shareholders are there?
As of Mar 2024, there are 48 institutional shareholders of Bicycle Therapeutics.
What percentage of Bicycle Therapeutics is owned by BAKER BROS. ADVISORS LP?
BAKER BROS. ADVISORS LP owns 4.94M shares of Bicycle Therapeutics, representing 11.65% of the company's total shares outstanding, valued at $123.08M (as of Mar 2024).
What percentage of Bicycle Therapeutics is owned by DEEP TRACK CAPITAL, LP?
As of Mar 2024, DEEP TRACK CAPITAL, LP holds 3.49M shares of Bicycle Therapeutics (BCYC), compromising 8.23% of the company, valued at $86.91M.
What percentage of Bicycle Therapeutics is owned by PARADIGM BIOCAPITAL ADVISORS LP?
PARADIGM BIOCAPITAL ADVISORS LP is the third largest holder of Bicycle Therapeutics. The company owns 3.25M of the company's shares outstanding (worth $80.84M).